Cargando…
The Evidence for High-Titer Convalescent Plasma in SARS-CoV-2
Convalescent plasma therapy has been used successfully in the past to treat respiratory infections. In SARS-CoV-2, there was initially strong evidence in favor of convalescent plasma therapy from a large observational study but the evidence from recent randomized controlled trials has been mixed. Ho...
Autores principales: | Fisher, David L., Alin, Pavel, Malnick, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891121/ https://www.ncbi.nlm.nih.gov/pubmed/33623865 http://dx.doi.org/10.1007/s42399-021-00827-1 |
Ejemplares similares
-
Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection
por: Hou, Hongyan, et al.
Publicado: (2021) -
Neurological Complications of SARS-CoV, MERS-CoV, and COVID-19
por: Alshebri, Munirah Saad, et al.
Publicado: (2020) -
Air filtration and SARS-CoV-2
por: Nazarenko, Yevgen
Publicado: (2020) -
Convalescent Plasma – Is it Useful for Treating SARS Co-V2 infection?
por: Ranganathan, Sudha, et al.
Publicado: (2020) -
Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 Pneumonia
por: Trunfio, Mattia, et al.
Publicado: (2022)